A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 13, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

August 3, 2021

Conditions
Healthy
Interventions
DRUG

BI 1323495

BI 1323495

DRUG

Placebo

Placebo

DRUG

Itraconazole

Itraconazole

Trial Locations (1)

130-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY